These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29037744)

  • 41. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
    Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP
    Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
    Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
    Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impaired Driving Associated with the Synthetic Cannabinoid 5f-Adb.
    McCain KR; Jones JO; Chilbert KT; Patton AL; James LP; Moran JH
    J Forensic Sci Criminol; 2018 Aug; 6(1):. PubMed ID: 30956998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
    Ivanov ID; Stoykova S; Ivanova E; Vlahova A; Burdzhiev N; Pantcheva I; Atanasov VN
    Forensic Sci Int; 2019 Apr; 297():372-377. PubMed ID: 30850157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
    Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
    Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
    Carlier J; Diao X; Sempio C; Huestis MA
    AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and Validation of a Novel All-Inclusive LC-MS-MS Designer Drug Method.
    Strickland EC; Cummings OT; Mellinger AL; McIntire GL
    J Anal Toxicol; 2019 Apr; 43(3):161-169. PubMed ID: 30462231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
    Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
    Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.
    Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR
    Drug Test Anal; 2019 Jul; 11(7):976-989. PubMed ID: 30838752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ
    Hutchison RD; Ford BM; Franks LN; Wilson CD; Yarbrough AL; Fujiwara R; Su MK; Fernandez D; James LP; Moran JH; Patton AL; Fantegrossi WE; Radominska-Pandya A; Prather PL
    Front Pharmacol; 2018; 9():1084. PubMed ID: 30319418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
    Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
    Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
    Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples.
    Gu K; Qin S; Zhang Y; Zhang W; Xin G; Shi B; Wang J; Wang Y; Lu J
    J Pharm Biomed Anal; 2022 Oct; 220():114985. PubMed ID: 35985137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Bovens M; Bissig C; Staeheli SN; Poetzsch M; Pfeiffer B; Kraemer T
    Forensic Sci Int; 2017 Dec; 281():98-105. PubMed ID: 29125990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unintentional Pediatric Exposure to a Synthetic Cannabinoid (AB-PINACA) Resulting in Coma and Intubation.
    Thornton SL; Akpunonu P; Glauner K; Hoehn KS; Gerona R
    Ann Emerg Med; 2015 Sep; 66(3):343-4. PubMed ID: 26304261
    [No Abstract]   [Full Text] [Related]  

  • 56. Stability of Synthetic Cannabinoids in Biological Specimens: Analysis Through Liquid Chromatography Tandem Mass Spectrometry.
    Fort C; Jourdan T; Jesse Kemp ; Curtis B
    J Anal Toxicol; 2017 Jun; 41(5):360-366. PubMed ID: 28334817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.
    Wilson CD; Tai S; Ewing L; Crane J; Lockhart T; Fujiwara R; Radominska-Pandya A; Fantegrossi WE
    J Pharmacol Exp Ther; 2019 Feb; 368(2):146-156. PubMed ID: 30420360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 2-alkyl-2
    Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
    Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
    Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
    Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic cannabinoids as designer drugs: new representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data.
    Shevyrin V; Melkozerov V; Nevero A; Eltsov O; Baranovsky A; Shafran Y
    Forensic Sci Int; 2014 Nov; 244():263-75. PubMed ID: 25305529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.